SCOTTSDALE, Ariz. (March 28, 2012) — Responses like these are sure to leave a good taste in algal omega-3 producers’ mouths.

Results of a U.S. consumer survey, conducted by Salt Lake City-based Discovery Research Group and released last week, suggest that more than a third of American supplement users — 37 per cent, to be exact — would prefer a source other than fish oil for their omega-3s.

Algae Biosciences Incorporated will soon begin commercial production of its ultra-pure omega-3 fatty acid oils, sourced from marine algae and grown in abundant Arizona sunlight, at its production facilities in the high desert plains near Holbrook.

When asked why they disliked fish oil, survey respondents, as reported by NutraIngredients-USA.com, gave reasons such as bad taste, bad aftertaste, fishy burps, bad smell, and large capsule size.

Dr. Mark Edwards, AlgaeBio’s Vice-President of Corporate Development and Marketing, has long felt the so-called “yuck factor” is a significant deterrent for fish oil-sourced omega-3 supplements.

“Many people are turned off by the unpleasant fish taste — and, even worse, the awful fishy burps — after ingesting omega-3 from fish,” says Dr. Edwards.

“Depleting the small fish in the ocean, and disrupting the marine food chain, is also a strong argument against fish-based omega-3s,” adds Dr. Edwards, a noted author and Arizona State University professor, whose recent work has focused on world hunger and sustainable energy with green solutions. “Globally, virtually every fishery is in decline due to overexploitation.”

In all, 705 American consumers were polled in the Discovery Research Group survey — all of whom take a multivitamin or other nutritional supplement, and confirmed an interest in overall health and fitness.

The survey was carried out in partnership with krill oil supplier Aker BioMarine Antarctic US — and NutraIngredients-USA.com reports that an executive with the company “acknowledged that algal omega-3 suppliers would also draw encouragement from the findings.”

AlgaeBio and Global Health Trax of Vista, Calif., have in place a sales and distribution contract that gives GHT exclusive rights to purchase and distribute AlgaeBio’s ultra-pure, omega-3 fatty acid oils to the nutraceutical, food additive, and animal feed markets.

Later this spring, AlgaeBio will complete a $5-million, first-phase expansion process at its production facilities, and begin large-scale commercial production of its highly regarded algal oils. The initial output of AlgaeBio’s algal oils will contain equal parts of the long-chain essential fatty acids EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) at a blended ratio of 40 per cent.

Algal-based omega-3 supplements are too new for any comprehensive research to have been carried out, but Dr. Edwards says “we believe there will be no identifiable taste or aftertaste” to the vegetable-based oils.

Slightly less than half of respondents polled in the Discovery Research Group/Aker BioMarine survey, or 48 per cent, take an omega-3 supplement. As for their reasons — with multiple responses allowed — 64 per cent answered “general health,” 58 per cent replied “heart health,” 27 per cent said “brain/cognitive health,” 26 per cent replied “joint health,” and 17 per cent said “healthy skin.”

Eric Anderson, Vice-President of Sales and Marketing at Aker BioMarine Antarctic US, told NutraIngredients-USA: “Clearly there is a market for consumers who want omega-3 supplements to increase these essential fatty acids in the diet, but do not want fish oil.”

SCOTTSDALE, Ariz. (Dec. 13, 2011) — In the laboratory, Algae Biosciences Incorporated uses green, golden, and red algae. As for the company’s manufacturing practices? Green. Decidedly green.

AlgaeBio, an Arizona biotechnology firm with production facilities in the high desert plains near Holbrook, is poised to take a leadership position in the global microalgae industry. Whether it’s food, biofuels, pollution solutions, or medicines, the algae industry’s competitive differentiators are sustainability and environmental symbiosis — and AlgaeBio is walking the walk, in addition to talking the talk.

“We use a totally ‘green’ production methodology at AlgaeBio,” says chairman of the board Robert J. Thompson. “Algae products are an incredibly valuable resource for mankind, and through every step of our production process, we’re able to keep our footprint environmentally positive.”

Topping AlgaeBio’s agenda, in the near future, is the production of ultra-pure omega-3 fatty acid oils for international customers in the rapidly expanding nutraceutical and food additive markets. Ground has been broken on AlgaeBio’s $5-million, first-phase expansion to its production facilities, and large-scale commercial production is expected by 2012.

The most obvious “green” aspect of AlgaeBio’s production is its use of the sun’s energy for algae growth. AlgaeBio’s fifth-generation bioreactors maximize the amount of sunlight available to algae cells swimming in pristine brine water, optimizing the growth process in a continuous, closed-loop system, whereas many competitors use a batch-process fermentation system for algae that never see the light of day.

Under a U.S. patent, AlgaeBio also has exclusive aquaculture use of pristine brine water, drawn from an aquifer directly beneath its plant location.

AlgaeBio maximizes every drop of this precious resource, using the brine water for multiple biomass production cycles before piping it to an outdoor pond to evaporate. The remaining salt is sold for use on roads and highways.

AlgaeBio’s extraction process, too, is a study in green. AlgaeBio uses supercritical carbon dioxide (CO2) to extract its algae oil.

“Our CO2 supplier can quantify what percentage of their product is supplied via the carbon-capture process,” says AlgaeBio co-founder and CEO Andrew Ayers. “In the future, we will be requesting a breakdown of where our CO2 is coming from.”

And speaking of AlgaeBio’s extraction process, the company does not use hexane, a hydrocarbon-based solvent, as some competitors do. Hence, there is no chance of possible residue — as AlgaeBio has opted for a clean-and-green pathway to deliver the optimal omega-3 product to consumers.

“The U.S. Food and Drug Administration sets a hexane level that they have determined is safe for human consumption, but if you don’t have to consume it at all, you don’t have to worry about safety levels,” remarks Ayers.

Finally, a clean and healthy byproduct of AlgaeBio’s omega-3 algae oil production is oxygen itself. For every gram of algae produced in the company’s bioreactors, approximately two grams of oxygen are released into the atmosphere.

AlgaeBio is quickly being recognized for its green manufacturing processes — in addition to its unabashedly green, health-boosting omega-3 products.

Thanks to AlgaeBio’s market-leading production capabilities, downstream opportunities include: pharmaceuticals, such as designer proteins, vaccines, enzymes, antibodies, and research agents; sustainable biofuels; macroalgae for human food; organic pigments that can replace synthetic dyes in food and cosmetics; organic compounds called carotenoids, which as potent antioxidants reduce cell damage and fight disease; and liquid feed for marine life.

-30-

ABOUT ALGAE BIOSCIENCES INCORPORATED: AlgaeBio is an Arizona biotechnology company that researches, develops, and manufactures ultra-pure products from micro and macro algae such as nutraceuticals, food additives, and pharmaceuticals. With access to near-perfect algae growing conditions, exclusive aquaculture access to a pristine brine water supply, and advanced proprietary technology, AlgaeBio produces superior human and animal consumable products, as well as offering advanced algae-based products and technologies for distribution into the agribusiness, biofuel, and aquaculture markets. AlgaeBio owns and operates large-scale production facilities near Holbrook, Ariz., and is a wholly owned subsidiary of Algae Biosciences Corporation.

SCOTTSDALE, Ariz. (December 6, 2011) — How long will Algae Biosciences Incorporated’s omega-3 fatty acid oils include a unique nutritional bonus? For about as long as there’s sunlight in the Arizona desert.

AlgaeBio, an Arizona biotechnology company, had previously announced that its ultra-pure omega-3 fatty acid oil offerings occupy a rare niche in the global marketplace — containing both EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid), the two most beneficial long-chain fatty acids that provide a wide range of health benefits.

And because AlgaeBio uses photosynthesis, rather than fermentation, to grow its microalgae, AlgaeBio’s resulting omega-3 fatty acid oils also include a host of accompanying compounds — including cancer-fighting carotenoids, cholesterol-lowering phytosterols, regenerative chlorophyll, and various vitamins — that provide a wide variety of health benefits.

It’s that free, plentiful sunlight in Arizona’s high desert plains near Holbrook — 360 days’ worth a year — as well as exclusive aquaculture use of pristine aquifer brine water, and a proprietary group of prolific marine algae species, that give AlgaeBio’s product the edge.

“These added benefits are unique to our omega-3 product,” says AlgaeBio president and co-founder Andrew Ayers. “The vast majority of the companies out there producing an omega-3 algae oil don’t use a photosynthetic process.

“And if you’re not using photosynthesis, the cells don’t produce these compounds — all the carotenoids, the chlorophylls, many of the phytosterols — because they’re not integral to the process.”

Topping AlgaeBio’s agenda, in the near future, is the production of ultra-pure omega-3 fatty acid oils for international customers in the rapidly expanding nutraceutical and food additive markets. Ground has been broken on AlgaeBio’s $5-million, first-phase expansion to its production facilities near Holbrook, and large-scale commercial production is expected by early 2012.

As for the added benefits provided by ol’ sol, AlgaeBio’s omega-3 fatty acid oils include three carotenoids — beta-carotene, lutein, and fucoxanthin.

Carotenoids boost the immune system, are believed to guard against certain types of cancer, and, because of their status as antioxidants, protect cells from the harmful effects of cigarette smoke, sunlight, and pollutants.

Carotenoids, particularly beta-carotene, also may help in the battle against heart disease by blocking the formation of bad cholesterol. Beta-carotene, the most well-known member of the carotenoid family, has powerful anti-aging properties. High intakes of lutein have been shown to reduce the risk of lung cancer, while beta-carotene decreases the risk of cervical cancer. Lutein also promotes clear vision by absorbing harmful UV rays, and help lower the risk of macular degeneration.

Chlorophyll helps to rebuild and replenish red blood cells, fights carcinogens, has strong antioxidant capacity, removes heavy metals such as mercury from the body, and has been found to help reduce inflammation.

It’s believed phytosterols, like carotenoids, work to reduce the amount of bad cholesterol entering the bloodstream. They also have a proven anti-inflammatory effect, as well as strong immune-enhancing properties, and are believed to improve the body’s production of insulin.

AlgaeBio’s omega-3 fatty acid oils also include Vitamin C and Vitamin E.

And because some of these compounds do act as antioxidants, AlgaeBio’s omega-3 fatty acid oils will also benefit from a longer shelf life.

Thanks to AlgaeBio’s market-leading production capabilities, downstream opportunities include: pharmaceuticals, such as designer proteins, vaccines, enzymes, antibodies, and research agents; sustainable biofuels; macroalgae for human food; organic pigments that can replace synthetic dyes in food and cosmetics; and liquid feed for marine life.

-30-

ABOUT ALGAE BIOSCIENCES INCORPORATED: AlgaeBio is an Arizona biotechnology company that researches, develops, and manufactures ultra-pure products from micro and macro algae such as nutraceuticals, food additives, and pharmaceuticals. With access to near-perfect algae growing conditions, exclusive aquaculture access to a pristine brine water supply, and advanced proprietary technology, AlgaeBio produces superior human and animal consumable products, as well as offering advanced algae-based products and technologies for distribution into the agribusiness, biofuel, and aquaculture markets. AlgaeBio owns and operates large-scale production facilities near Holbrook, Ariz., and is a wholly owned subsidiary of Algae Biosciences Corporation.

SCOTTSDALE, Ariz. (Dec. 2, 2011) — It appears that lowly algae is causing a stratospheric stir.

Dr. Mark Edwards, the Vice-President of Corporate Development and Marketing with Algae Biosciences Incorporated, wrote and presented two scientific papers promoting algae’s enormous potential for the 100 Year Starship Study public symposium in Orlando, Fla., in early October.

Dr. Edwards’ papers — one focusing on habitats and environmental science, the other on biology and space medicine — have been submitted for possible publication in the Journal of the British Interplanetary Society as part of the 100 Year Starship Study, an initiative spearheaded by the United States government’s Defense Advance Research Project Agency (DARPA) in collaboration with NASA’s Ames Research Center.

Dr. Edwards’ paper on habitats and environmental science focuses on algae-based smart microfarms, which produce sustainable food and animal feed high in nutrient density, as well as oxygen and other forms of energy. Algae microfarms can also recycle the existing waste stream, while organic algae biofertilizers accelerate growth of plants grown in water, air, or soil.

The subject struck a responsive chord in high-ranking NASA officialdom.

“NASA’s scientist responsible for habitat on the International Space Station, from the United States’ perspective, was involved in the review session for this paper,” says Dr. Edwards, an Arizona State University professor, award-winning author, and celebrated “algae evangelist.”

“They’ve been talking about using algae to moderate the habitat, provide some food, and clean the air in the International Space Station,” adds Dr. Edwards.

“It was interesting meeting her and hearing her responses; NASA doesn’t tell the world who’s who in their business. And she was very complimentary. She said this is exactly the kind of thing we’d need to do if we went far into space.”

AlgaeBio, an Arizona biotechnology company, is positioning itself to take a leadership role in the global microalgae industry in the coming months. Topping AlgaeBio’s agenda, in the near future, is the production of ultra-pure omega-3 fatty acid oils for international customers in the rapidly expanding nutraceutical and food additive markets. Ground has been broken on AlgaeBio’s $5-million, first-phase expansion to its production facilities near Holbrook, and large-scale commercial production is expected by early 2012.

DARPA’s 100 Year Starship project is intended to lay the groundwork for interstellar travel over the next century, while delivering spinoff benefits along the way.

Dr. Edwards’ paper on biology and space medicine makes note of algae’s potential in the production of medicine, vaccines, and antibodies. Both of Dr. Edwards’ papers were co-authored by Robert Henrikson of Richmond, Calif., and Mark Buehrer of Bellingham, Wash.

Dr. Edwards will be discussing his 100YSS habitats and environmental science paper in detail in upcoming chapters of his Algae’s Promise blog, which is written exclusively for AlgaeBio and posted on the company’s website (www.algaebio.com)

Thanks to AlgaeBio’s market-leading production capabilities, downstream opportunities include: pharmaceuticals, such as designer proteins, vaccines, enzymes, antibodies, and research agents; sustainable biofuels; macroalgae for human food; organic pigments that can replace synthetic dyes in food and cosmetics; organic compounds called carotenoids, which as potent antioxidants reduce cell damage and fight disease; and liquid feed for marine life.

-30-

ABOUT ALGAE BIOSCIENCES INCORPORATED: AlgaeBio is an Arizona biotechnology company that researches, develops, and manufactures ultra-pure products from micro and macro algae such as nutraceuticals, food additives, and pharmaceuticals. With access to near-perfect algae growing conditions, exclusive aquaculture access to a pristine brine water supply, and advanced proprietary technology, AlgaeBio produces superior human and animal consumable products, as well as offering advanced algae-based products and technologies for distribution into the agribusiness, biofuel, and aquaculture markets. AlgaeBio owns and operates large-scale production facilities near Holbrook, Ariz., and is a wholly owned subsidiary of Algae Biosciences Corporation.

SCOTTSDALE, Ariz. (November 15, 2011) — It’s said by some that there’s no accounting for taste. Obviously, those folks haven’t encountered the Algae BioMax™ system

Algae Biosciences Incorporated, an Arizona biotechnology company, recently launched Algae BioMax™ — a system that efficiently delivers algae-based nutrients to crops through standard irrigation systems, and represents a potentially groundbreaking development in the agricultural sector.

For the past two years, AlgaeBio has collaborated with a major international producer and distributor of fresh produce to develop and refine the Algae BioMax™ system at a large Arizona melon crop farm. Through this extended field study, Algae BioMax™ surpassed even the most optimistic predictions by improving crop yields — an astonishing 38 per cent for cantaloupes, and a truly astronomical 92 per cent for honeydew melons — while also enhancing crop size, germination rate, time to maturity, and health and vitality.

The proof of the pudding, of course, is in the eating. And the Algae BioMax™-fertilized melons grown as part of the pilot project, in addition to creating other crop market value assets, proved a true taste sensation.

“We had various scientific analyses performed on the fruit. They told us about the nutritional improvements that Algae BioMax™ provides, and gave a strong indication of fruit quality and extended shelf life,” notes Dr. Mark Edwards, Vice-President of Corporate Development and Marketing at Algae Biosciences Incorporated. “But the best gauge came from the human palate — the taste test. And in that regard, the Algae BioMax™ melons scored extraordinarily high.”

Blind taste tests from the Algae BioMax™ pilot project, carried out at Arizona State University, overwhelmingly favored the Algae BioMax™-fertilized melons.

The preference ratio was 17-to-1 for honeydew melons, and 15-to-1 for cantaloupes, over melons from a corresponding controlled crop grown at the same farm. Test subjects said they preferred the sweeter taste, more intense color, and firmer texture of the Algae BioMax™-treated melons.

In addition to dramatically improving crop yield and producing melons that command superior market value, the Algae BioMax™ system significantly enhances a farmer’s net revenue in two other key areas: reducing production costs by curtailing the need for chemical fertilizers, fuel, and herbicides; and improving soil porosity and fertility. These aspects of Algae BioMax™’s game-changing effectiveness will be highlighted separately in future AlgaeBio media advisories.

In terms of nutritional improvements, AlgaeBio contracted Dallas-based Food Safety Net Services to develop an independent nutritional profile of the Algae BioMax™-treated melons and the controlled crop — with revealing results.

Algae-infused cantaloupes contained three times the sugar, and 60 per cent more Vitamin C, in comparison to the control-crop melons, while Algae BioMax™-fertilized honeydew melons contained 50 per cent more sugar.

A separate report from an independent laboratory commissioned by the international fresh produce firm reported that essential micronutrients such as boron, chromium, copper, fluoride, iodine, iron, magnesium, molybdenum, selenium, sulfur, and zinc were on average 250 per cent higher in the Algae BioMax™-treated melons — because algae naturally deliver micronutrients that were otherwise unavailable in the degraded soil used during the pilot project.

Brix and firmness tests also confirmed the benefits of the Algae BioMax™ system. Fruit producers use the Brix scale as the measure of sugar (one degree of Brix equals a gram of sucrose in 100 grams of solution), and growers covet higher Brix levels, because a higher sugar density means better taste. Algae BioMax™ melons rated a 13 to 14 on the Brix scale, compared to a 9 to 10 rating ascribed to a competitor’s melon.

Fruit producers also treasure firmness — because consumers prefer stronger texture, and firmer fruit has a longer shelf life. Firmness levels are based on the pressure required to penetrate the open side of the melon; Algae BioMax™ melons rated a 7.3 for firmness, compared to a 5.5 rating for a competitor’s melon.

“It’s clear from these results that Algae BioMax™ has had a profound impact on crop market value,” says AlgaeBio’s co-founder and Chief Executive Officer Andrew Ayers. “The Algae BioMax™-fertilized melons have more vitamins, minerals, and digestible nutrients.

“They’ve got a longer shelf life, which means producers can ship them further and they last longer in the store. And they score incredibly high for firmness, texture, color, and taste.”

Algae BioMax™ delivers 74 bioavailable nutrients, vitamins, and trace elements, precisely when they’re needed, to maximize crop germination, growth, and development. The Algae BioMax™ system is believed to be beneficial to all manner of agricultural crops, including grains, oilseeds, legumes, fruits, and vegetables.

AlgaeBio has filed a U.S. patent application for the Algae BioMax™ system, and continues to develop and refine the system to further assess benefits, operating partnerships, and market potential.

-30-

ABOUT ALGAE BIOSCIENCES INCORPORATED: AlgaeBio is an Arizona biotechnology company that researches, develops, and manufactures ultra-pure products from micro and macro algae such as nutraceuticals, food additives, and pharmaceuticals. With access to near-perfect algae growing conditions, exclusive aquaculture access to a pristine brine water supply, and advanced proprietary technology, AlgaeBio produces superior human and animal consumable products, as well as offering advanced algae-based products and technologies for distribution into the agribusiness, biofuel, and aquaculture markets. AlgaeBio owns and operates large-scale production facilities near Holbrook, Ariz., and is a wholly owned subsidiary of Algae Biosciences Corporation.

SCOTTSDALE, Ariz. (November 8, 2011) — It looks as though “algae evangelist” Dr. Mark Edwards has a few more believers.

Dr. Edwards, Vice-President of Corporate Development and Marketing at Algae Biosciences Incorporated, is an outspoken advocate regarding algae’s potential in freedom foods, agribusiness, and sustainable energy. An Arizona State University professor, Dr. Edwards is also an award-winning author — with another accolade now requiring space in the trophy case.

Abundance, which advocates a revolutionary approach to agriculture by endorsing the growth of sustainable, fossil-free foods, has won the 2011 Pinnacle Award for Best Book in the Environment category.

Contemporary industrial foods are grown in genetic monocultures and suffer from “hidden hunger” due to worn-out soils, delivering empty calories from nutrient dilution that promote diabetes and obesity in our children, writes Dr. Edwards. The abundance approach, meanwhile, reverses nutrient dilution and pollution by cleaning and repairing ecosystems, and uses plentiful, non-fossil resources that will not run out — sunshine, carbon dioxide, and non-potable water.

Nutrients in “freedom foods,” which are superior in taste and nutrition, contain 85 per cent less fat and cholesterol than industrial foods while delivering 50 to 200 per cent more vitamins, minerals and antioxidants, offering a wide array of health benefits. Eating low on the food chain, writes Dr. Edwards, yields significant benefits for consumer health, growers, and our planet.

“Abundance growing methods mimic nature with algae to produce food, feeds, fertilizers, and other forms of energy using non-fossil resources,” says Dr. Edwards.

“Abundance regenerates ecosystems and will enable us to leave a positive legacy for our children — affordable, healthy foods, plentiful natural resources, and robust ecosystems.”

Dr. Edwards has published more than 100 articles encompassing business and science disciplines, and the most recent nine of his 18 books are part of the Green Algae Strategy Series, which focuses on sustainable and affordable food and energy production.

Two previous works by Dr. Edwards were also award winners. Green Algae Strategy, published in 2009, won an Independent Publisher (IPPY) Book Awards gold medal. Meanwhile, The Tiny Plant That Saved Our Planet, released in 2010, earned a silver medal in the Best Children’s Book category at the 2011 Nautilus Book Awards.

Edwards’ books are used in colleges, universities, and other halls of learning in more than a dozen countries for courses in biology, botany, biotechnology, the environment, sustainability, energy engineering, and global hunger. His ongoing Algae 101 column was named the No. 1 visited site by AlgaeIndustryMagazine.com earlier this year.

This fall, Dr. Edwards was chosen to present two scientific papers promoting the wonders of algae for the 100 Year Starship Study, an initiative spearheaded by the United States government’s Defense Advance Research Project Agency (DARPA) in collaboration with the NASA Ames Research Center. Dr. Edwards presented his papers — one in the habitats and environmental science category, the other in biology and space medicine — during the 100 Year Starship Study public symposium at Orlando, Fla., held between Sept. 30 and Oct. 2.

-30-

ABOUT ALGAE BIOSCIENCES INCORPORATED: AlgaeBio is an Arizona biotechnology company that researches, develops, and manufactures ultra-pure products from micro and macro algae such as nutraceuticals, food additives, and pharmaceuticals. With access to near-perfect algae growing conditions, exclusive aquaculture access to a pristine brine water supply, and advanced proprietary technology, AlgaeBio produces superior human and animal consumable products, as well as offering advanced algae-based products and technologies for distribution into the agribusiness, biofuel, and aquaculture markets. AlgaeBio owns and operates large-scale production facilities near Holbrook, Ariz., and is a wholly owned subsidiary of Algae Biosciences Corporation.

SCOTTSDALE, Ariz. (Nov. 1, 2011) — On a bleak patch of ground known as the Devil’s Hole, an agricultural breakthrough is bearing fruit.

Algae Biosciences Incorporated, an Arizona biotechnology company, recently launched the Algae BioMax™ system — a potentially groundbreaking development in the agricultural sector. For the past two years, in collaboration with a major international producer and distributor of fresh produce, AlgaeBio has been developing and refining the Algae BioMax™ system, which efficiently delivers algae-based nutrients to crops through standard irrigation systems.

When this extended pilot project began at a large Arizona melon crop farm, a plot of land called the Devil’s Hole was deliberately selected. The field in question had been abandoned by a previous farmer, and was essentially worthless because of the soil’s high salt content, pH of 9.2, and systematic loss of organic matter over 30 years of harvests — the perfect spot to prove Algae BioMax™’s mettle.

And the results were no less than astonishing.

“There was no better place than the Devil’s Hole for us to show how well algae worked as a nutrient delivery system — and the Algae BioMax™ system proved it, beyond the shadow of a doubt,” says Dr. Mark Edwards, AlgaeBio’s Vice-President of Corporate Development and Marketing.

“Across the board, Algae BioMax™ improved the yield, size, germination rate, time to maturity, and health and vitality of the crop,” adds Dr. Edwards. “It’s not a stretch to suggest that this may be the most important breakthrough in agriculture since the Green Revolution of the 1950s.”

The Algae BioMax™ system significantly enhances a farmer’s net revenue in three other key areas: improving the market value of the crop by enhancing taste, color, and texture, and adding more vitamins, minerals, and essential micronutrients; reducing production costs by curtailing the need for chemical fertilizers, fuel, and herbicides; and improving soil porosity and fertility. These aspects of Algae BioMax™’s game-changing effectiveness will be highlighted separately in future AlgaeBio media advisories.

In terms of crop growth, development, and yield, Algae BioMax™ demonstrated startling success. Through this extended field study conducted with the international fresh produce firm — one trial involving cantaloupes, the other involving honeydew melons — production numbers at the Arizona melon crop farm exceeded the grower’s highest yield improvement expectations.

The algae-infused crop of cantaloupes produced an astonishingly higher yield — 38 per cent more fruit — than the corresponding controlled crop. Meanwhile, the algae-infused crop of honeydew melons yielded numbers that were truly astronomical — producing 92 per cent more fruit, nearly double the volume of the controlled crop.

Metrics conducted by the international fresh produce firm also showed striking growth differences. The algae-infused field produced melons that were 2.4 times as large as their controlled-crop counterparts, according to early figures; other favorable comparisons included plant height (2.6 times as large), plant radius (2.3), and size of flower (2.6), stem (2.5), and trunk (2.9).

Melon plants treated with the Algae BioMax™ system also experienced higher germination rates and faster early growth, as well as early maturity — allowing the farmer, significantly, to harvest the fields nine days early on a 12-week growing season. Algae-infused plants were also strengthened against extreme weather, drought, and pests.

The Algae BioMax™ system is believed to be beneficial to all manner of agricultural crops, including grains, oilseeds, legumes, fruits, and vegetables.

Algae BioMax™ delivers 74 bioavailable nutrients, vitamins, and trace elements, precisely when they’re needed, to maximize crop germination, growth, and development, explains AlgaeBio co-founder and Chief Executive Officer Andrew Ayers.

“Algae has been providing plants nutrients since land plants evolved from algae 500 million years ago,” says Ayers.

“Algae BioMax™ mimics nature . . . and plants react immediately to their favored source of nutrients.”

AlgaeBio has filed a U.S. patent application for the Algae BioMax™ system, and continues to develop and refine the system to further assess benefits, operating partnerships, and market potential.

-30-

ABOUT ALGAE BIOSCIENCES INCORPORATED: AlgaeBio is an Arizona biotechnology company that researches, develops, and manufactures ultra-pure products from micro and macro algae such as nutraceuticals, food additives, and pharmaceuticals. With access to near-perfect algae growing conditions, exclusive aquaculture access to a pristine brine water supply, and advanced proprietary technology, AlgaeBio produces superior human and animal consumable products, as well as offering advanced algae-based products and technologies for distribution into the agribusiness, biofuel, and aquaculture markets. AlgaeBio owns and operates large-scale production facilities near Holbrook, Ariz., and is a wholly owned subsidiary of Algae Biosciences Corporation.

SCOTTSDALE, Ariz. (Oct. 25, 2011) — No spin doctoring required . . . this piece of equipment will mean big things for the algae industry.

Evodos B.V., a Dutch manufacturer of centrifugal systems, recently made a gift of a state-of-the-art centrifuge to Dr. Mark Edwards, Vice-President of Corporate Development and Marketing at Algae Biosciences Incorporated. Dr. Edwards, a professor at Arizona State University, an award-winning author, and an outspoken advocate regarding algae’s potential in freedom foods, agribusiness and sustainable energy, had researched and promoted Evodos B.V.’s products through their formative stages.

Evodos B.V. is expected to present a Type 2/10 SPT Harvester centrifuge, worth an estimated $50,000, to Dr. Edwards at the Algae Biomass Summit at Minneapolis, Minn., on Oct. 27. Dr. Edwards has graciously allowed AlgaeBio, an Arizona biotechnology company, to press the centrifuge into service as it begins producing ultra-pure omega-3 fatty acid oils for international customers in the nutraceutical and food additive sectors in the coming months. Dr. Edwards and AlgaeBio’s research team will perform a series of extraction tests with the Evodos Harvester that will be shared with the algae industry.

“It’s quite an honour. A very nice gesture. I wouldn’t have been so enthusiastic about the product unless I thought it was special,” says Edwards. “And this unit is a huge breakthrough for the industry. It’s not a full solution, but it really goes a long way toward solving the harvest and extraction step.

“That’s been a real sticking point in the algae industry. It’s why a lot of companies failed. They were able to grow the algae, but they weren’t able to harvest it efficient. This centrifuge unit reduces the harvesting costs by a factor of 10, by using far less energy. And this wonderful unit will be a big help to us at AlgaeBio.”

Marco Brocken, Chief Executive Officer of Evodos B.V., says Dr. Edwards’ research and feedback on early prototypes of the Evodos Harvester were vital to its evolution.

“Mark was one of two scientists worldwide, along with Mario Tredici of Florence, Italy, who recognized the possibilities of our centrifugal technology in an early stage. Their reactions gave us the courage to continue developing our centrifugal machine,” says Brocken. “Of his own accord, Mark has been very supportive in bringing Evodos technology to the attention of key people in the algae industry.

“Based on his support, Evodos has chosen the algae industry as the focal point of our business,” adds Brocken. “Our harvesting products are now purchased and delivered across the world to countries such as USA, Canada, Chile, Australia, Spain, and our home country, the Netherlands.”

AlgaeBio announced in mid-August a $5-million, first-phase expansion to its production facilities near Holbrook, Ariz., which will allow the company to reach large-scale commercial production levels of omega-3 fatty acid oils by early 2012.

While AlgaeBio already has a larger Evodos B.V. centrifuge on order, the Type 2/10 SPT Harvester unit will perfectly suit the company’s initial needs.

“The traditional problem with harvesting microalgae from sea water, specifically, is that the density between the (algae) cell and the media (sea water and nutrients) is very small,” says Andy Ayers, AlgaeBio’s co-founder and Chief Executive Officer. “In order to remove the algae from the water, in the past, producers have had to use extremely high G-force centrifuges, which can have detrimental effects on the algae, because they generate heat in the process.

“This unit runs at a much slower RPM, resulting in less heat and less damage to the product.”

Thanks to AlgaeBio’s market-leading production capabilities, downstream opportunities include: pharmaceuticals, such as designer proteins, vaccines, enzymes, antibodies, and research agents; sustainable biofuels; macroalgae for human food; organic pigments that can replace synthetic dyes in food and cosmetics; organic compounds called carotenoids, which as potent antioxidants reduce cell damage and fight disease; and liquid feed for marine life.

-30-

ABOUT ALGAE BIOSCIENCES INCORPORATED: AlgaeBio is an Arizona biotechnology company that researches, develops, and manufactures ultra-pure products from micro and macro algae such as nutraceuticals, food additives, and pharmaceuticals. With access to near-perfect algae growing conditions, exclusive aquaculture access to a pristine brine water supply, and advanced proprietary technology, AlgaeBio produces superior human and animal consumable products, as well as offering advanced algae-based products and technologies for distribution into the agribusiness, biofuel, and aquaculture markets. AlgaeBio owns and operates large-scale production facilities near Holbrook, Ariz., and is a wholly owned subsidiary of Algae Biosciences Corporation.

SCOTTSDALE, Ariz. (Oct. 19, 2011) — Algae Biosciences Incorporated makes exceptional products from algae. And now, it’s easier to stay exceptionally well-informed about the company’s accomplishments.

AlgaeBio, an Arizona biotechnology company with production facilities in the high desert plains near Holbrook, has relaunched its website at www.algaebio.com — with company news, financial information, and views from a world-renowned algae industry expert only a few clicks away.

“AlgaeBio aims to be an industry-leading algae research, development, and product manufacturer, and is focused on assuming a prominent position on the world stage,” says AlgaeBio Chairman Robert J. Thompson. “Accordingly, our new website has the look that befits a progressive, innovative pacesetter.”

AlgaeBio is poised to become a global leader in the microalgae industry in the coming months. Topping the company’s agenda, on a short-term basis, is the production of ultra-pure omega-3 fatty acid oils for international customers in the rapidly expanding nutraceutical and food additive markets.

The www.algaebio.com website will prominently feature the Algae’s Promise blog, written by Dr. Mark Edwards — an Arizona State University professor, award-winning author, and renowned “algae evangelist,” who also happens to be the Vice-President of Corporate Development and Marketing for AlgaeBio.

Dr. Edwards will be updating the Algae’s Promise blog on a biweekly basis with developments in the algae industry, and the role AlgaeBio is playing in boosting algae’s profile in freedom foods, agribusiness, and sustainable energy.

“Algae’s Promise will explore current and future algae products and applications that will lift human societies,” says Dr. Edwards.

“It will also examine therapeutic discoveries that reverse chronic disease and enhance human and animal health and vitality.

“In addition,” adds Dr. Edwards, “we will also use Algae’s Promise to look at new discoveries that enable functional foods; nutraceuticals, human, animal, and plant nutrition; multiple forms of bioenergy; and air, water, and soil remediation and regeneration.”

AlgaeBio’s revamped website will also feature the latest company news, a landing page for multimedia presentations, and a sign-up form for those who wish to receive regular AlgaeBio electronic correspondence.

The website also features regular AlgaeBio financial statements and management discussion and analysis documents, as well as detailed AlgaeBio stock quote information, updates, and historical data powered by QuoteMedia.

The website includes links to AlgaeBio’s social media presence, including the company’s Twitter and Facebook home pages.

AlgaeBio announced in mid-August a $5-million, first-phase expansion to its production facilities in northeast Arizona, which will allow the company to reach large-scale commercial production levels by early 2012.

Thanks to AlgaeBio’s market-leading production capabilities, downstream opportunities include: pharmaceuticals, such as designer proteins, vaccines, enzymes, antibodies, and research agents; sustainable biofuels; macroalgae for human food; organic pigments that can replace synthetic dyes in food and cosmetics; organic compounds called carotenoids, which as potent antioxidants reduce cell damage and fight disease; and liquid feed for marine life.

-30-

ABOUT ALGAE BIOSCIENCES INCORPORATED: AlgaeBio is an Arizona biotechnology company that researches, develops, and manufactures ultra-pure products from micro and macro algae such as nutraceuticals, food additives, and pharmaceuticals. With access to near-perfect algae growing conditions, exclusive aquaculture access to a pristine brine water supply, and advanced proprietary technology, AlgaeBio produces superior human and animal consumable products, as well as offering advanced algae-based products and technologies for distribution into the agribusiness, biofuel, and aquaculture markets. AlgaeBio owns and operates large-scale production facilities near Holbrook, Ariz., and is a wholly owned subsidiary of Algae Biosciences Corporation.

SCOTTSDALE, Ariz. (Sept. 27, 2011) — In the words of a former osculation-obsessed game-show host: “And the survey says . . .!”
Dr. Mark Edwards, Vice-President of Corporate Development and Marketing at Algae Biosciences Incorporated, is preparing to release the results of his annual Algal Biomass Organization (ABO) Algae Industry Survey this fall.

As per usual, this year’s survey polls hundreds of industry producers, scientists, technicians, suppliers, support professionals, and academics worldwide. Dr. Edwards is tentatively scheduled to release and discuss the most recent results during the fifth annual Algae Biomass Summit, which runs from Oct. 24 to 27 at Minneapolis, Minn.

“This survey is an industry barometer of sorts. It gives the industry some strategic direction,” says Dr. Edwards, an Arizona State University professor, award-winning author, and renowned “algae evangelist” who focuses on algae’s potential in freedom foods, agribusiness, and sustainable energy.

“The ABO’s director has used it multiple times to lobby Congress. It quantifies various topics. It prioritizes a lot of issues in the industry. It’s really a big deal.”

AlgaeBio, an Arizona biotechnology company, is positioning itself to take a leadership role in the global microalgae industry in the coming months. Topping AlgaeBio’s agenda, on a short-term basis, is the production of ultra-pure omega-3 fatty acid oils for international customers in the nutraceutical and food additive sectors.

AlgaeBio announced in mid-August a $5-million, first-phase expansion to its production facilities near Holbrook, Ariz., which will allow the company to reach large-scale commercial production levels by very early 2012.

The initial phase of expansion calls for the manufacture and incorporation of 1,500 of AlgaeBio’s proprietary bioreactors, as well as harvesting and support equipment, which will be housed in a new addition to the facility.

The ABO’s annual Algae Industry Survey quizzes respondents in the areas of input and production challenges, social and economic issues, and product potential. More than a third of respondents have more than five years’ experience in the industry.

This year’s survey has also added questions about new jobs created in the algae industry. “The ethanol industry has always been about jobs, but in the algae industry, we haven’t been on that platform, so to speak,” says Dr. Edwards. “We thought it was time to ask those questions and see what kind of answers we got.”

This year’s Algae Biomass Summit will bring together industry professionals from all over the world, including the biofuels, animal feeds, supplements and foods, bioplastics, fertilizers, carbon partitioning, genetic systems, and engineering sectors.

Thanks to AlgaeBio’s market-leading production capabilities, downstream opportunities include: pharmaceuticals, such as designer proteins, vaccines, enzymes, antibodies, and research agents; sustainable biofuels; macroalgae for human food; organic pigments that can replace synthetic dyes in food and cosmetics; organic compounds called carotenoids, which as potent antioxidants reduce cell damage and fight disease; and liquid feed for marine life.

-30-

ABOUT ALGAE BIOSCIENCES INCORPORATED: AlgaeBio is an Arizona biotechnology company that researches, develops, and manufactures ultra-pure products from micro and macro algae such as nutraceuticals, food additives, and pharmaceuticals. With access to near-perfect algae growing conditions, exclusive aquaculture access to a pristine brine water supply, and advanced proprietary technology, AlgaeBio produces superior human and animal consumable products, as well as offering advanced algae-based products and technologies for distribution into the agribusiness, biofuel, and aquaculture markets. AlgaeBio owns and operates large-scale production facilities near Holbrook, Ariz., and is a wholly owned subsidiary of Algae Biosciences Corporation.